Long-term effects of postnatal 6-hydroxydopamine treatment on tissue catecholamine levels.
D000311:Adrenal Glands / Q000187:drug effects; D000367:Age Factors; D000818:Animals; D001835:Body Weight / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000032:analysis*; D004298:Dopamine / Q000032:analysis; D004305:Dose-Response Relationship, Drug; D005260:Female; D006321:Heart / Q000187:drug effects; D006892:Hydroxydopamines / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D009206:Myocardium / Q000032:analysis; D009638:Norepinephrine / Q000032:analysis; D009929:Organ Size; D009928:Organ Specificity; D049590:Postpartum Period; D011247:Pregnancy; D051381:Rats; D013154:Spleen / Q000032:analysis
D002395:Catecholamines; D006892:Hydroxydopamines; D004298:Dopamine; D009638:Norepinephrine